A double-blind, placebo-controlled study
β
Barry J. Snow; Fiona L. Rolfe; Michelle M. Lockhart; Christopher M. Frampton; Jo
π
Article
π
2010
π
John Wiley and Sons
π
English
β 104 KB
π 1 views
## Abstract Multiple lines of evidence point to mitochondrial oxidative stress as a potential pathogenic cause for Parkinson's disease (PD). MitoQ is a powerful mitochondrial antioxidant. It is absorbed orally and concentrates within mitochondria where it has been shown to protect against oxidative